The company previously announced data from another Phase III trial of cebranopadol, which also met its primary endpoint.

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Health technology is changing the way we treat pain. Orthokine Therapy uses the body’s own healing proteins to reduce ...

The results of the study indicate that certain clinical and genetic factors significantly influence therapy dropout. The ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

Chronic pain treatment benefits from a holistic approach that integrates physical therapy and behavioral health.

C. In a move to provide advanced solutions for chronic pain sufferers, OrthoNebraska is now offering minimally invasive ...

A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

PCRX-201 became part of Pacira's portfolio in 2021, but was originally developed at Baylor and then by GQ Bio Therapeutics, ...

In HIV-positive MSM, pain severity was significantly associated with pain management experiences and unhealthy alcohol use.

The global cold laser therapy market is poised for steady growth over the next decade, driven by the rising adoption of non-invasive pain management solutions and continuous advancements in ...

Fyzical Therapy & Balance CentersSo something that's unique about fyzical is their saftey overhead support system which is what i'm in right now and essentiall ...